ASO Author Reflections: Beyond the Binary: Using IHC Status to Predict Response to Neoadjuvant Therapy in HER2+ Early-Stage Breast Cancer

被引:0
|
作者
Leah K. Winer [1 ]
Austin D. Williams [2 ]
机构
[1] University of Kentucky,Division of Surgical Oncology, Department of Surgery
[2] Fox Chase Cancer Center,Division of Breast Surgery, Department of Surgical Oncology
关键词
D O I
10.1245/s10434-024-16606-w
中图分类号
学科分类号
摘要
引用
收藏
页码:967 / 968
页数:1
相关论文
共 50 条
  • [1] ASO Author Reflections: Beyond the Binary: Using IHC Status to Predict Response to Neoadjuvant Therapy in HER2+Early-Stage Breast Cancer
    Winer, Leah K.
    Williams, Austin D.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (02) : 967 - 968
  • [2] ASO Author Reflections: Evolving Multidisciplinary Decision Making for Early-Stage, HER2-Positive Breast Cancer
    Muppidi, Natasha
    Adesoye, Taiwo
    Hunt, Kelly K.
    Teshome, Mediget
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (13) : 8908 - 8909
  • [3] Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer
    Nicola Cosgrove
    Alex J. Eustace
    Peter O’Donovan
    Stephen F. Madden
    Bruce Moran
    John Crown
    Brian Moulton
    Patrick G. Morris
    Liam Grogan
    Oscar Breathnach
    Colm Power
    Michael Allen
    Janice M. Walshe
    Arnold D. Hill
    Anna Blümel
    Darren O’Connor
    Sudipto Das
    Małgorzata Milewska
    Joanna Fay
    Elaine Kay
    Sinead Toomey
    Bryan T. Hennessy
    Simon J. Furney
    npj Breast Cancer, 9
  • [4] ASO Author Reflections: Breast-Conserving Therapy: A Safe Option in Young Patients with Early-Stage Breast Cancer
    Orozco, Javier I. J.
    Fancher, Crystal E.
    Grumley, Janie G.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (10) : 6311 - 6312
  • [5] ASO Author Reflections: Role of Genomic Assay to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
    Pease, Alison M.
    James, Ted A.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (Suppl 3) : S573 - S574
  • [6] ASO Author Reflections: Breast-Conserving Therapy: A Safe Option in Young Patients with Early-Stage Breast Cancer
    Javier I. J. Orozco
    Crystal E. Fancher
    Janie G. Grumley
    Annals of Surgical Oncology, 2022, 29 : 6311 - 6312
  • [7] ASO Author Reflections: Role of Genomic Assay to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
    Alison M. Pease
    Ted A. James
    Annals of Surgical Oncology, 2019, 26 : 573 - 574
  • [8] Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer
    Cosgrove, Nicola
    Eustace, Alex J.
    O'Donovan, Peter
    Madden, Stephen F.
    Moran, Bruce
    Crown, John
    Moulton, Brian
    Morris, Patrick G.
    Grogan, Liam
    Breathnach, Oscar
    Power, Colm
    Allen, Michael
    Walshe, Janice M.
    Hill, Arnold D.
    Blumel, Anna
    O'Connor, Darren
    Das, Sudipto
    Milewska, Malgorzata
    Fay, Joanna
    Kay, Elaine
    Toomey, Sinead
    Hennessy, Bryan T.
    Furney, Simon J.
    NPJ BREAST CANCER, 2023, 9 (01)
  • [9] ASO Author Reflections: What will be Required to Safely Omit Breast Surgery for Early-Stage Breast Cancer?
    Makoto Ishitobi
    Naoki Hayashi
    Annals of Surgical Oncology, 2021, 28 : 2553 - 2554
  • [10] ASO Author Reflections: What will be Required to Safely Omit Breast Surgery for Early-Stage Breast Cancer?
    Ishitobi, Makoto
    Hayashi, Naoki
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (05) : 2553 - 2554